Table 2 Numbers of individuals in the study and incidence rates for all relevant cardiovascular diseases and all relevant heart diseases, including and excluding events recorded as conduction defects and pericardial effusion, by age and sex

Females

1–9

(10.8%)

(135-217)

(84-151)

(117-194)

(66-127)

10–19

(11.8%)

(279-370)

(114-175)

(256-343)

(92-147)

20–29

(11.7%)

(555-695)

(267-367)

(494-628)

(209-298)

30–39

(13.9%)

(886-1042)

(558-683)

(714-855)

(387-493)

40–49

(16.3%)

(1859-2051)

(1397-1564)

(1459-1629)

(996-1138)

50–54

(6.9%)

(3175-3541)

(2675-3011)

(2394-2713)

(1893-2178)

55–59

(6.3%)

(4698-5174)

(3966-4404)

(3633-4052)

(2899-3275)

60–64

(6.5%)

(6719-7290)

(5860-6393)

(5128-5628)

(4274-4730)

65–69

(4.8%)

(10 063-10 801)

(9073-9773)

(7629-8272)

(6647-7247)

70–74

(3.9%)

(16 438-17 529)

(15 090-16 135)

(12 273-13 214)

(10 885-11 771)

75–79

(3.1%)

(27 007-28 559)

(25 159-26 657)

(19 976-21 307)

(18 122-19 389)

80–84

(2.2%)

(41 233-43 475)

(38 966-41 141)

(30 150-32 053)

(27 906-29 735)

 ≥ 85

(2.0%)

(71 975-75 039)

(68 780-71 768)

(52 979-55 579)

(49 856-52 373)

Total individuals

(100.0%)

-

-

-

-

No. of cases

-

-

-

-

Total person-years

-

-

-

-

Crude rate

(6883-7031)

(6239-6380)

(5225-5354)

(4574-4695)

Age-standardized  rate

(6861-7008)

(6214-6354)

(5156-5283)

(4508-4627)

Males

1–9

(11.5%)

(178-269)

(98-169)

(150-234)

(71-133)

10–19

(13.1%)

(261-345)

(127-187)

(241-322)

(107-164)

20–29

(12.5%)

(416-531)

(244-333)

(386-496)

(214-298)

30–39

(14.5%)

(847-1000)

(673-810)

(718-859)

(545-668)

40–49

(17.2%)

(2767-2999)

(2497-2718)

(2289-2500)

(2019-2218)

50–54

(7.2%)

(5537-6017)

(5117-5578)

(4512-4946)

(4087-4500)

55–59

(6.3%)

(8792-9446)

(8166-8796)

(6903-7483)

(6273-6826)

60–64

(6.1%)

(11 990-12 777)

(11 081-11 837)

(9256-9947)

(8349-9005)

65–69

(4.3%)

(16 563-17 567)

(15 272-16 236)

(12 617-13 493)

(11 309-12 138)

70–74

(3.1%)

(24 568-26 045)

(22 831-24 253)

(18 521-19 799)

(16 742-17 956)

75–79

(2.2%)

(36 200-38 305)

(33 201-35 213)

(27 177-28 990)

(24 159-25 865)

80–84

(1.3%)

(52 658-55 867)

(48 843-51 924)

(39 840-42 606)

(35 926-38 545)

 ≥ 85

(0.8%)

(84 586-89 530)

(78 162-82 893)

(65 294-69 585)

(58 835-62 890)

Total individuals

(100.0%)

-

-

-

-

No. of cases

-

-

-

-

Total person-years

-

-

-

-

Crude rate

(7340-7494)

(6744-6892)

(5752-5889)

(5141-5270)

Age-standardized rate

(9503-9703)

(8727-8918)

(7343-7518)

(6558-6723)

Both sexes combined

1–9

(11.1%)

(167-229)

(99-147)

(143-200)

(76-118)

10–19

(12.4%)

(281-343)

(128-171)

(259-318)

(107-146)

20–29

(12.1%)

(497-587)

(267-333)

(452-538)

(223-284)

30–39

(14.2%)

(887-997)

(633-726)

(735-835)

(481-563)

40–49

(16.7%)

(2343-2493)

(1974-2112)

(1901-2036)

(1531-1653)

50–54

(7.0%)

(4416-4718)

(3952-4237)

(3506-3775)

(3038-3289)

55–59

(6.3%)

(6801-7204)

(6115-6498)

(5320-5676)

(4631-4964)

60–64

(6.3%)

(9354-9835)

(8466-8923)

(7202-7624)

(6316-6711)

65–69

(4.5%)

(13 299-13 842)

(12 093-12 678)

(10 075-10 609)

(8934-9436)

70–74

(3.5%)

(20 264-21 159)

(18 735-19 594)

(15 235-16 009)

(13 663-14 395)

75–79

(2.6%)

(31 141-32 404)

(28 801-30 013)

(23 241-24 326)

(20 885-21 912)

80–84

(1.7%)

(45 999-47 850)

(43 129-44 917)

(34 205-35 788)

(31 307-32 818)

≥ 85

(1.4%)

(76 426-79 038)

(72 214-74 745)

(57 275-59 510)

(53 097-55 242)

Total individuals

(100.0%)

-

-

-

-

No. of cases

-

-

-

-

Total person-years

-

-

-

-

Crude rate

(7131-7238)

(6509-6611)

(5505-5598)

(4872-4960)

Age-standardized rate

(8041-8161)

(7354-7470)

(6129-6233)

(5438-5537)